BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21437364)

  • 1. [Drug advertising and promotion: regulations and extent of compliance in five Latin American countries].
    Vacca C; Vargas C; Cañás M; Reveiz L
    Rev Panam Salud Publica; 2011 Feb; 29(2):76-83. PubMed ID: 21437364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of advertising material distributed through pharmacies and drugstores.
    Galato D; Pereira GB; Valgas C
    Rev Saude Publica; 2011 Feb; 45(1):212-5. PubMed ID: 21181059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia.
    Al-Aqeel SA; Al-Sabhan JF; Sultan NY
    Pharm Pract (Granada); 2013 Jul; 11(3):138-43. PubMed ID: 24223078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of international code of marketing breast-milk substitutes in China.
    Liu A; Dai Y; Xie X; Chen L
    Breastfeed Med; 2014 Nov; 9(9):467-72. PubMed ID: 25026262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Over the counter drugs--a new era in Israel].
    Abadi-Korek I; Vaknin S; Marom E; Shemer J; Luxenburg O
    Harefuah; 2011 Jan; 150(1):29-32, 69, 68. PubMed ID: 21449153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of drug advertising in Spanish gynecology journals].
    Diez B; Hidalgo A
    Gac Sanit; 2012; 26(3):270-3. PubMed ID: 22088908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of drug promotion.
    Silverman M
    Int J Health Serv; 1977; 7(2):157-66. PubMed ID: 856741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy advertising: sense and nonsense on the web pages of the best-selling pharmaceuticals in Spain.
    Chilet-Rosell E; Martín Llaguno M; Ruiz Cantero MT; Alonso-Coello P
    BMC Public Health; 2010 Mar; 10():134. PubMed ID: 20233393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance of infant formula promotion on websites of Brazilian manufacturers and drugstores.
    Prado ISCF; Rinaldi AEM
    Rev Saude Publica; 2020; 54():12. PubMed ID: 32049209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What patients think about promotional activities of pharmaceutical companies in Turkey.
    Semin S; Güldal D; Ozçakar N; Mevsim V
    Pharm World Sci; 2006 Aug; 28(4):199-206. PubMed ID: 17066242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
    Vilhelmsson A; Davis C; Mulinari S
    PLoS Med; 2016 Jan; 13(1):e1001945. PubMed ID: 26812151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legislation analysis according to WHO and INCB criteria on opioid availability: a comparative study of 5 countries and the state of Texas.
    Liliana De Lima MH; Sakowski JA; Stratton Hill C; Bruera E
    Health Policy; 2001 May; 56(2):99-110. PubMed ID: 11275300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct-to-consumer advertising of prescription drugs.
    Frosch DL; Grande D
    LDI Issue Brief; 2010; 15(3):1-4. PubMed ID: 20469541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms.
    Sheikhan NY; Pinto AM; Nowak DA; Abolhassani F; Lefebvre P; Duh MS; Witek TJ
    JAMA Netw Open; 2021 Jul; 4(7):e2116551. PubMed ID: 34251442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.